215 related articles for article (PubMed ID: 23554857)
1. Targeting CDH17 suppresses tumor progression in gastric cancer by downregulating Wnt/β-catenin signaling.
Qiu HB; Zhang LY; Ren C; Zeng ZL; Wu WJ; Luo HY; Zhou ZW; Xu RH
PLoS One; 2013; 8(3):e56959. PubMed ID: 23554857
[TBL] [Abstract][Full Text] [Related]
2. Targeting cadherin-17 inactivates Wnt signaling and inhibits tumor growth in liver carcinoma.
Liu LX; Lee NP; Chan VW; Xue W; Zender L; Zhang C; Mao M; Dai H; Wang XL; Xu MZ; Lee TK; Ng IO; Chen Y; Kung HF; Lowe SW; Poon RT; Wang JH; Luk JM
Hepatology; 2009 Nov; 50(5):1453-63. PubMed ID: 19676131
[TBL] [Abstract][Full Text] [Related]
3. CDH17 is a downstream effector of HOXA13 in modulating the Wnt/β-catenin signaling pathway in gastric cancer.
Qu LP; Zhong YM; Zheng Z; Zhao RX
Eur Rev Med Pharmacol Sci; 2017 Mar; 21(6):1234-1241. PubMed ID: 28387908
[TBL] [Abstract][Full Text] [Related]
4. Cadherin-17 induces tumorigenesis and lymphatic metastasis in gastric cancer through activation of NFκB signaling pathway.
Wang J; Kang WM; Yu JC; Liu YQ; Meng QB; Cao ZJ
Cancer Biol Ther; 2013 Mar; 14(3):262-70. PubMed ID: 23298905
[TBL] [Abstract][Full Text] [Related]
5. Knockdown of liver-intestine cadherin decreases BGC823 cell invasiveness and metastasis in vivo.
Xu Y; Zhang J; Liu QS; Dong WG
World J Gastroenterol; 2012 Jun; 18(24):3129-37. PubMed ID: 22791949
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of CDH17 gene expression via RNA interference reduces proliferation and apoptosis of human MKN28 gastric cancer cells.
Li R; Yang HQ; Xi HL; Feng S; Qin RH
Int J Oncol; 2017 Jan; 50(1):15-22. PubMed ID: 27909714
[TBL] [Abstract][Full Text] [Related]
7. TC1(C8orf4) correlates with Wnt/beta-catenin target genes and aggressive biological behavior in gastric cancer.
Kim B; Koo H; Yang S; Bang S; Jung Y; Kim Y; Kim J; Park J; Moon RT; Song K; Lee I
Clin Cancer Res; 2006 Jun; 12(11 Pt 1):3541-8. PubMed ID: 16740781
[TBL] [Abstract][Full Text] [Related]
8. Targeting cadherin-17 inactivates Ras/Raf/MEK/ERK signaling and inhibits cell proliferation in gastric cancer.
Lin Z; Zhang C; Zhang M; Xu D; Fang Y; Zhou Z; Chen X; Qin N; Zhang X
PLoS One; 2014; 9(1):e85296. PubMed ID: 24465527
[TBL] [Abstract][Full Text] [Related]
9. Overexpression of FOXS1 in gastric cancer cell lines inhibits proliferation, metastasis, and epithelial-mesenchymal transition of tumor through downregulating wnt/β-catenin pathway.
Lu Q; Ma X; Li Y; Song W; Zhang L; Shu Y; Wan B
J Cell Biochem; 2019 Mar; 120(3):2897-2907. PubMed ID: 30500980
[TBL] [Abstract][Full Text] [Related]
10. Lentiviral-mediated miRNA against liver-intestine cadherin suppresses tumor growth and invasiveness of human gastric cancer.
Liu QS; Zhang J; Liu M; Dong WG
Cancer Sci; 2010 Aug; 101(8):1807-12. PubMed ID: 20500517
[TBL] [Abstract][Full Text] [Related]
11. Knockdown of NCOA2 Inhibits the Growth and Progression of Gastric Cancer by Affecting the Wnt Signaling Pathway-Related Protein Expression.
Lin Z; Yang F; Lu D; Sun W; Zhu G; Lan B
Technol Cancer Res Treat; 2020; 19():1533033820928072. PubMed ID: 32489143
[TBL] [Abstract][Full Text] [Related]
12. DDAH1 mediates gastric cancer cell invasion and metastasis via Wnt/β-catenin signaling pathway.
Ye J; Xu J; Li Y; Huang Q; Huang J; Wang J; Zhong W; Lin X; Chen W; Lin X
Mol Oncol; 2017 Sep; 11(9):1208-1224. PubMed ID: 28580735
[TBL] [Abstract][Full Text] [Related]
13. Silencing of WISP3 suppresses gastric cancer cell proliferation and metastasis and inhibits Wnt/β-catenin signaling.
Fang F; Zhao WY; Li RK; Yang XM; Li J; Ao JP; Jiang SH; Kong FZ; Tu L; Zhuang C; Qin WX; He P; Zhang WM; Cao H; Zhang ZG
Int J Clin Exp Pathol; 2014; 7(10):6447-61. PubMed ID: 25400723
[TBL] [Abstract][Full Text] [Related]
14. RACK1 suppresses gastric tumorigenesis by stabilizing the β-catenin destruction complex.
Deng YZ; Yao F; Li JJ; Mao ZF; Hu PT; Long LY; Li G; Ji XD; Shi S; Guan DX; Feng YY; Cui L; Li DS; Liu Y; Du X; Guo MZ; Xu LY; Li EM; Wang HY; Xie D
Gastroenterology; 2012 Apr; 142(4):812-823.e15. PubMed ID: 22240482
[TBL] [Abstract][Full Text] [Related]
15. UBE3C promotes proliferation and inhibits apoptosis by activating the β-catenin signaling via degradation of AXIN1 in gastric cancer.
Zhang Y; Xu J; Fu H; Wei Z; Yang D; Yan R
Carcinogenesis; 2021 Feb; 42(2):285-293. PubMed ID: 32930707
[TBL] [Abstract][Full Text] [Related]
16. TRIM58 suppresses the tumor growth in gastric cancer by inactivation of β-catenin signaling via ubiquitination.
Liu X; Long Z; Cai H; Yu S; Wu J
Cancer Biol Ther; 2020; 21(3):203-212. PubMed ID: 31747856
[No Abstract] [Full Text] [Related]
17. Downregulation of long noncoding RNA LINC00460 expression suppresses tumor growth in vitro and in vivo in gastric cancer.
Zhang S; Xu J; Wang H; Guo H
Cancer Biomark; 2019; 24(4):429-437. PubMed ID: 30909185
[TBL] [Abstract][Full Text] [Related]
18. LINC00665 induces gastric cancer progression through activating Wnt signaling pathway.
Yang B; Bai Q; Chen H; Su K; Gao C
J Cell Biochem; 2020 Mar; 121(3):2268-2276. PubMed ID: 31736127
[TBL] [Abstract][Full Text] [Related]
19. ING5 suppresses proliferation, apoptosis, migration and invasion, and induces autophagy and differentiation of gastric cancer cells: a good marker for carcinogenesis and subsequent progression.
Gou WF; Shen DF; Yang XF; Zhao S; Liu YP; Sun HZ; Su RJ; Luo JS; Zheng HC
Oncotarget; 2015 Aug; 6(23):19552-79. PubMed ID: 25980581
[TBL] [Abstract][Full Text] [Related]
20. Blockade of proliferation and migration of gastric cancer via targeting CDH17 with an artificial microRNA.
Zhang J; Liu QS; Dong WG
Med Oncol; 2011 Jun; 28(2):494-501. PubMed ID: 20393816
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
